BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion

Ropes & Gray represented Becton, Dickinson and Company, BD, in a definitive agreement to acquire Edwards Lifesciences' Critical Care product group, a leader in advanced hemodynamic monitoring solutions, for $4.2 billion in cash. The transaction was announced in a June 3 press release.

The complementary acquisition will expand BD's portfolio of smart connected care solutions with a broad set of hemodynamic monitoring technologies, advanced AI-enabled clinical decision tools and a robust innovation pipeline. BD is one of the largest global medical technology companies in the world, with more than 70,000 employees.

The team included mergers & acquisitions partners Emily Oldshue and Marko Zatylny and associate Tyler Silvey, counsel Georgina Jones Suzuki, tax partner Benjamin Rogers, executive compensation & employee benefits partner Jenny Rikoski Whitney, antitrust partners Jonathan Klarfeld and Ruchit Patel, healthcare partner Jennifer Romig, data, privacy & cybersecurity partner Ed McNicholas, life sciences regulatory & compliance partners Josh Oyster, Lincoln Tsang and Katherine Wang, employment partner Richard Kidd and real estate partner David Kaye.